Eur Respir J 2000; 16: 514-533
Copyright © ERS Journals Ltd 2000
Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research
J Van Schoor,
GF Joos,
and
RA Pauwels
Bronchial hyperresponsiveness (BHR), an abnormal increase in airflow limitation following the exposure to a stimulus, is an important pathophysiological characteristic of bronchial asthma. Because of heterogeneity of the airway response to different stimuli, the latter have been divided into direct and indirect stimuli. Direct stimuli cause airflow limitation by a direct action on the effector cells involved in the airflow limitation, while indirect stimuli exert their action essentially on inflammatory and neuronal cells that act as an intermediary between the stimulus and the effector cells. This manuscript reviews the clinical and experimental studies on the mechanisms involved in indirect BHR in patients with asthma. Pharmacological stimuli (adenosine, tachykinins, bradykinin, sodium metabisulphite/sulphur dioxide, and propranolol) as well as physical stimuli (exercise, nonisotonic aerosols, and isocapnic hyperventilation) are discussed. The results of the different direct and indirect bronchial challenge tests are only weakly correlated and are therefore not mutually interchangeable. Limited available data (studies on the effects of allergen avoidance and inhaled corticosteroids) suggest that indirectly acting bronchial stimuli (especially adenosine) might better reflect the degree of airway inflammation than directly acting stimuli. It remains to be established whether monitoring of indirect BHR as a surrogate marker of inflammation (in addition to symptoms and lung function) is of clinical relevance to the long-term management of asthmatic patients. This seems to be the case for the direct stimulus methacholine. More work needs to be performed to find out whether, indirect stimuli are more suitable in asthma monitoring than direct ones. Recommendations on the application of indirect challenges in clinical practice and research will shortly be available from the European Respiratory Society Task Force.
This article has been cited by other articles:

|
 |

|
 |
 
P. J. Sterk, C. Y. Yick, and A. M. Slats
The secret life of steroids in asthma
Eur. Respir. J.,
November 1, 2008;
32(5):
1135 - 1137.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Reynolds, R. Docherty, J. Robbins, D. Spina, and C. P. Page
Adenosine induces a cholinergic tracheal reflex contraction in guinea pigs in vivo via an adenosine A1 receptor-dependent mechanism
J Appl Physiol,
July 1, 2008;
105(1):
187 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Loland and H. Bisgaard
Feasibility of Repetitive Lung Function Measurements by Raised Volume Rapid Thoracoabdominal Compression During Methacholine Challenge in Young Infants
Chest,
January 1, 2008;
133(1):
115 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes
Against the dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases.
Am. J. Respir. Crit. Care Med.,
August 1, 2006;
174(3):
240 - 243.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lin, M. Nieda, J. F. Hutton, V. Rozenkov, and A. J. Nicol
Comparative gene expression analysis of NKT cell subpopulations
J. Leukoc. Biol.,
July 1, 2006;
80(1):
164 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Bergren
Prostaglandin involvement in lung C-fiber activation by substance P in guinea pigs
J Appl Physiol,
June 1, 2006;
100(6):
1918 - 1927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. K. Basoglu, A. Pelleg, S. Essilfie-Quaye, C. Brindicci, P. J. Barnes, and S. A. Kharitonov
Effects of Aerosolized Adenosine 5'-Triphosphate vs Adenosine 5'-Monophosphate on Dyspnea and Airway Caliber in Healthy Nonsmokers and Patients With Asthma
Chest,
October 1, 2005;
128(4):
1905 - 1909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Frossard, E. Naline, C. Olgart Hoglund, O. Georges, and C. Advenier
Nerve growth factor is released by IL-1{beta} and induces hyperresponsiveness of the human isolated bronchus
Eur. Respir. J.,
July 1, 2005;
26(1):
15 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Nielsen and H. Bisgaard
Hyperventilation with Cold versus Dry Air in 2- to 5-Year-Old Children with Asthma
Am. J. Respir. Crit. Care Med.,
February 1, 2005;
171(3):
238 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.W.M. Willemse, N.H.T. ten Hacken, B. Rutgers, I.G.A.T. Lesman-Leegte, W. Timens, and D.S. Postma
Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD
Eur. Respir. J.,
September 1, 2004;
24(3):
391 - 396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Lee, J.-W. Liao, and J.-J. Kang
Motorcycle Exhaust Particles Induce Airway Inflammation and Airway Hyperresponsiveness in BALB/C Mice
Toxicol. Sci.,
June 1, 2004;
79(2):
326 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Luijk, R.D. Kempsford, A.M. Wright, P. Zanen, and J-W.J. Lammers
Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction
Eur. Respir. J.,
April 1, 2004;
23(4):
559 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. O. Koskela, L. Hyvarinen, J. D. Brannan, H.-K. Chan, and S. D. Anderson
Responsiveness to Three Bronchial Provocation Tests in Patients With Asthma
Chest,
December 1, 2003;
124(6):
2171 - 2177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. KUMAR, S. LNU, R. MALYA, D. BARRON, J. MOORE, D. B. CORRY, and A. M. BORIEK
Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma
FASEB J,
October 1, 2003;
17(13):
1800 - 1811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Panditi and M Silverman
Perception of exercise induced asthma by children and their parents
Arch. Dis. Child.,
September 1, 2003;
88(9):
807 - 811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.F. Joos and B. O'Connor
Indirect airway challenges
Eur. Respir. J.,
June 1, 2003;
21(6):
1050 - 1068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kerzel, G. Path, W. A. Nockher, D. Quarcoo, U. Raap, D. A. Groneberg, Q. T. Dinh, A. Fischer, A. Braun, and H. Renz
Pan-Neurotrophin Receptor p75 Contributes to Neuronal Hyperreactivity and Airway Inflammation in a Murine Model of Experimental Asthma
Am. J. Respir. Cell Mol. Biol.,
February 1, 2003;
28(2):
170 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-P. Boulet
Asymptomatic Airway Hyperresponsiveness: A Curiosity or an Opportunity to Prevent Asthma?
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
371 - 378.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Hannon, B. Tigani, H.-J. Schuurman, and J. R. Fozard
Suppression of Adenosine A3 Receptor-Mediated Hypotension and Mast Cell Degranulation in the Rat by Dexamethasone
J. Pharmacol. Exp. Ther.,
August 1, 2002;
302(2):
725 - 730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.F. Joos
Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma?
Eur. Respir. J.,
September 1, 2001;
18(3):
439 - 441.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Cockcroft
How Best to Measure Airway Responsiveness
Am. J. Respir. Crit. Care Med.,
June 1, 2001;
163(7):
1514 - 1515.
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the European Respiratory Society.
|